Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis

This study delves into the exploration of bioactive constituents derived from Salvia officinalis and Glycyrrhiza glabra, with a focus on their potential to modulate peroxisome proliferator-activated receptor gamma (PPARG), a crucial regulator of glucose homeostasis and a key target for diabetes management. Through the rigorous application of in silico methodologies, the interactions between PPARG and six natural compounds, including kanzonol X, glabrol, linolenic acid, glycyrrhizin, carnosic acid, and licoflavone A, were meticulously examined. Molecular docking studies unveiled a notable binding affinity between kanzonol X and glabrol to the PPARG receptor, indicating their potential effectiveness in regulating blood glucose levels through PPARG activation. Molecular dynamics simulations affirmed the stability of the PPARG-ligand complexes, highlighting the significance of hydrogen bonds in maintaining their stability. Furthermore, computational techniques were utilized to assess the absorption, distribution, metabolism, and excretion (ADME) properties as well as the compounds’ cardiotoxicity. Encouragingly, these natural substances exhibited efficient cellular uptake, favorable bioavailability, and demonstrated no cardiotoxic effects. Kanzonol X and glabrol, abundant in G. glabra, have emerged as strong candidates for regulating blood glucose levels regulation through PPARG activation. Although computational methodologies have offered vital insights, unlocking the full potential of these compounds necessitates rigorous research and clinical trials to validate the effectiveness and safety of kanzonol X and glabrol in managing diabetes for this patient population.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis

Cited by 3 publications

References 37 publications

Letter to the Editor regarding articles on lobeglitazone

Letter to the Editor regarding articles on lobeglitazone

Will lobeglitazone rival pioglitazone? A systematic review and critical appraisal

PPARG modulation by bioactive compounds from Salvia officinalis and Glycyrrhiza glabra in type 2 diabetes management: A in silico study

Contact Info

Product

Resources

About